ArticleClinical, cosmetic and investigational dermatology2026
Treatment for Filler-Induced Alopecia with Concentrated Growth Factors.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyaluronic acid (HA) is widely used for non-surgical facial rejuvenation but is associated with risks, including rare filler-induced alopecia (FIA) in the temporal and frontal regions. While subcutaneous hyaluronidase (HAase) injection is the standard treatment, we report an alternative approach using concentrated growth factor (CGF) injections. A 29-year-old female presented with a pruritic alopecic patch in the right temporal region that appeared 20 days after receiving HA filler injection. A well-demarcated 6×4 cm alopecic patch persisted despite prior treatment with HAase. The patient subsequently underwent four CGF injections. During the ten-month follow-up, significant hair regrowth was observed. This case suggests that CGF monotherapy is a promising treatment for FIA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.